AstraZeneca stock has the potential to push above $61 per share, aided in part by the drug maker's …

The deal has clear gains for both sides, but AstraZeneca's shares slid 6% after news of the UK firm…

AstraZeneca on Saturday announced it was acquiring Alexion Pharmaceuticals in a $39 billion deal, a…

The departures come at a moment of "great corporate strength and momentum," Alexion chairman Dr. Le…

Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…

US stocks gained on Friday after a day of market declines as investor concerns about rising inflati…

If inflation doesn't cool off soon, the Fed could be forced to change course sooner than it has bee…

Kontopoulos says she's constantly looking at the biotech space as a whole, guided by a "mental chec…

One approach that has caught attention is the link between responses to treatments and the microbio…

A bipartisan $908 billion stimulus measure is expected to be formally introduced on Monday. Congres…

To figure out which ones to invest in, Kontopoulos said she uses a a 10-item "mental checklist." Th…

Triple-negative breast cancer is an aggressive form of the disease, quicker to recur and spread. Im…

"Synageva is an ideal strategic and operational fit for Alexion that aligns with what we know well …

He's recommending companies with strong returns on invested capital since the Global Financial Cris…

New York City Mayor Bill de Blasio warned that the city should prepare for another full shutdown as…

Microsoft climbed to a record intraday high after announcing a $40 billion share buyback program an…

Shares of Facebook tumbled as much as 2.4% after New York Attorney General Letitia James announced …

The early gains were reversed after the University of Michigan said its consumer-sentiment index re…

Analysts from UBS predict Hurricane Dorian could cost insurance companies more than $25 billion as …

A gauge for American manufacturing posted a contraction in August for the first time in almost a de…